Resultados de búsqueda - Masaomi Iyo
- Mostrando 1 - 20 Resultados de 26
- Ir a la Siguiente Página
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Phencyclidine-Induced Cognitive Deficits in Mice Are Improved by Subsequent Subchronic Administration of the Novel Selective α7 Nicotinic Receptor Agonist SSR180711 por Kenji Hashimoto, Tamaki Ishima, Yūkō Fujita, Masaaki Matsuo, Tatsuhiro Kobashi, Makoto Takahagi, Hideo Tsukada, Masaomi Iyo
Publicado 2007Artigo -
11
Transporting Cognitive Behavioral Therapy (CBT) and the Improving Access to Psychological Therapies (IAPT) project to Japan: preliminary observations and service evaluation in Chib... por Osamu Kobori, Michiko Nakazato, Naoki Yoshinaga, Tetsuya Shiraishi, Kota Takaoka, Akiko Nakagawa, Masaomi Iyo, Eiji Shimizu
Publicado 2014Artigo -
12
-
13
-
14
An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia por Akihiro Shiina, Nobuhisa Kanahara, Tsuyoshi Sasaki, Yasunori Oda, Tasuku Hashimoto, Tadashi Hasegawa, Taisuke Yoshida, Masaomi Iyo, Kenji Hashimoto
Publicado 2015Artigo -
15
High occupancy of σ1 receptors in the human brain after single oral administration of donepezil: a positron emission tomography study using [11C]SA4503 por Masatomo Ishikawa, Muneyuki Sakata, Kenji Ishii, Yuichi Kimura, Keiichi Oda, Jun Toyohara, Jin Wu, Kiichi Ishiwata, Masaomi Iyo, Kenji Hashimoto
Publicado 2009Artigo -
16
Relationship between perception and anxiety about COVID-19 infection and risk behaviors for spreading infection: A national survey in Japan por Akihiro Shiina, Tomihisa Niitsu, Osamu Kobori, Keita Idemoto, Tasuku Hashimoto, Tsuyoshi Sasaki, Yoshito Igarashi, Eiji Shimizu, Michiko Nakazato, Kenji Hashimoto, Masaomi Iyo
Publicado 2020Artigo -
17
Negative Correlation between Brain Glutathione Level and Negative Symptoms in Schizophrenia: A 3T 1H-MRS Study por Daisuke Matsuzawa, Takayuki Obata, Yukihiko Shirayama, Hiroi Nonaka, Yôko Kanazawa, Eiji Yoshitome, Jun‐ichi Takanashi, Tsuyoshi Matsuda, Eiji Shimizu, Hiroo Ikehira, Masaomi Iyo, Kenji Hashimoto
Publicado 2008Artigo -
18
A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia por Akihiro Shiina, Yukihiko Shirayama, Tomihisa Niitsu, Tasuku Hashimoto, Taisuke Yoshida, Tadashi Hasegawa, T. Haraguchi, Nobuhisa Kanahara, Tetsuya Shiraishi, Mihisa Fujisaki, Goro Fukami, Michiko Nakazato, Masaomi Iyo, Kenji Hashimoto
Publicado 2010Artigo -
19
Decreased Serum Levels of Mature Brain-Derived Neurotrophic Factor (BDNF), but Not Its Precursor proBDNF, in Patients with Major Depressive Disorder por Taisuke Yoshida, Masatomo Ishikawa, Tomihisa Niitsu, Michiko Nakazato, Hiroyuki Watanabe, Tetsuya Shiraishi, Akihiro Shiina, Tasuku Hashimoto, Nobuhisa Kanahara, Tadashi Hasegawa, Masayo Enohara, Atsushi Kimura, Masaomi Iyo, Kenji Hashimoto
Publicado 2012Artigo -
20
Dietary glucoraphanin prevents the onset of psychosis in the adult offspring after maternal immune activation por Akiko Matsuura, Tamaki Ishima, Yūkō Fujita, Yoshimi Iwayama, Shunsuke Hasegawa, Ryouka Kawahara‐Miki, Motoko Maekawa, Manabu Toyoshima, Yusuke Ushida, Hiroyuki Suganuma, Satoshi Kida, Takeo Yoshikawa, Masaomi Iyo, Kenji Hashimoto
Publicado 2018Artigo
Herramientas de búsqueda:
Materias Relacionadas
Medicine
Psychology
Internal medicine
Psychiatry
Receptor
Schizophrenia (object-oriented programming)
Psychosis
Biochemistry
Biology
Endocrinology
Chemistry
Cognition
Pharmacology
Neuroscience
Agonist
Antagonist
Antipsychotic
Anxiety
Disease
Pathology
Alternative medicine
Dementia
Developmental psychology
Dopamine
Genetics
Glutamate receptor
Hippocampus
NMDA receptor
Risperidone
Amino acid